Ann: Pancreatic cancer clinical study update, page-17

Yep, pretty much my views. I have stated before that they may make a good target for SRX or BTG, both of which have good relationships with medics in the area of expertise within the centres. With SRX having over 700 centres in the Americas this would fast track the marketing. The US, with rather generous reimbursement, is where the action is.

I still think the last ANN is just part of the problem with current management. There needs to be a clean out and some serious folks put in, that can be a little more realistic with SH expectations. This complete nonsense with the CE mark over the past year shows, IMO, that current management are playing in a kiddies playground and have little honesty when dealing with SH.

If the CE mark takes many months, due to a number of reasons then why keep saying in the next couple of months / near future etc? Naive at best, but either way not a company I can put my hard earned into. Maybe one day.